Metastatic medullary thyroid carcinoma: a new way forward

Medullary thyroid carcinoma (MTC) is a rare malignancy comprising 1–2% of all thyroid cancers in the United States. Approximately 20% of cases are familial, secondary to a germline RET mutation, while the remaining 80% are sporadic and also harbour a somatic RET mutation in more than half of all cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Angelousi, Anna, Hayes, Aimee R, Chatzellis, Eleftherios, Kaltsas, Gregory A, Grossman, Ashley B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175549/
https://www.ncbi.nlm.nih.gov/pubmed/35521769
http://dx.doi.org/10.1530/ERC-21-0368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175549/
https://www.ncbi.nlm.nih.gov/pubmed/35521769
http://dx.doi.org/10.1530/ERC-21-0368

Ejemplares similares